Eeva™ System Clinical Study

To validate the Eeva System technology, Auxogyn has initiated its first clinical study. This observational study will evaluate embryos from four IVF clinics in the San Francisco Bay Area listed below.

The goal of this study is to demonstrate that the Eeva System may be used to identify embryos at cleavage stage (day 3) that are most likely to form blastocysts (day 5). These predictions will be compared to the actual blastocyst outcome as observed at the clinical sites. Further information on the criteria for patient eligibility and study methods is available at www.ClinicalTrials.gov.

If you are a patient interested in enrolling in this study, please contact one of the sites listed above.

Additional clinical studies will be required prior to commercial distribution of the device in the U.S., and are in the planning stages.